BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) People

BlossomHill Therapeutics, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Carl Gordon
Other companies: ADARx Pharmaceuticals, Inc. (Co-head Global Private Equity at OrbiMed Advisors · Since at least Sep 24, 2026); Electra Therapeutics, Inc. (Director · Since at least Sep 18, 2026); Scribe Therapeutics Inc. (Director · Since at least Jul 23, 2026); Compass Therapeutics, Inc. (Founding Member, Managing Partner, and Co-Head of Global Private Equity, OrbiMed Advisors LLC · Since at least Jun 17, 2020); Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); MBX Biosciences, Inc. (Director · Sep 12, 2024 – Feb 14, 2025 · Past); ArriVent BioPharma, Inc. (Director · Jan 25, 2024 – Jan 30, 2024 · Past); Theseus Pharmaceuticals Inc (Director · Oct 6, 2021 – Feb 14, 2024 · Past); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Terns Pharmaceuticals, Inc. (Director · Feb 4, 2021 – Jul 15, 2024 · Past); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Adicet Bio, Inc. (Director · Sep 15, 2020 – Aug 21, 2024 · Past); ORIC Pharmaceuticals, Inc. (Director · Apr 23, 2020 – Jun 16, 2021 · Past); SpringWorks Therapeutics Inc (Director · Sep 12, 2019 – Sep 12, 2019 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Jun 15, 2020 · Past); Alector, Inc. (Director · Feb 6, 2019 – May 10, 2019 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 27, 2016 · Past); Intellia Therapeutics, Inc. (Director · May 5, 2016 – May 18, 2017 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Sep 18, 2013 · Past); Pacira BioSciences, Inc. (Director · Feb 2, 2011 – Feb 8, 2011 · Past); Amarin Corporation plc (Director · Dec 30, 2010 – Sep 4, 2012 · Past); BioCryst Pharmaceuticals, Inc. (Director · May 17, 2006 – May 17, 2006 · Past)
Board Member · Since at least Aug 6, 2026
Bihua Chen
Other companies: Helix Acquisition Corp. III (Chairperson and CEO, Director · Since at least Jan 22, 2026); BridgeBio Oncology Therapeutics, Inc. (Director · Since at least Feb 8, 2024); Biomea Fusion, Inc. (Director · Since at least Apr 15, 2021); Erasca, Inc. (Director · Jul 15, 2021 – Jun 22, 2023 · Past); Monte Rosa Therapeutics, Inc. (Director · Jun 23, 2021 – Jun 23, 2021 · Past); Verve Therapeutics Inc (Director · Jun 16, 2021 – Jun 21, 2021 · Past); Rain Oncology Inc (Director · Apr 22, 2021 – Apr 27, 2021 · Past); Design Therapeutics, Inc. (Director · Mar 25, 2021 – Mar 25, 2021 · Past); Prometheus Biosciences Inc (Director · Mar 11, 2021 – Mar 11, 2021 · Past); BioAtla, Inc. (Director · Dec 15, 2020 – Dec 18, 2020 · Past); Olema Pharmaceuticals, Inc. (Director · Nov 18, 2020 – Nov 23, 2020 · Past); Atea Pharmaceuticals, Inc. (Director · Oct 29, 2020 – Nov 3, 2020 · Past); MoonLake Immunotherapeutics (CEO and Chairman, Director · Oct 19, 2020 – Oct 22, 2020 · Past); Akouos Inc (Director · Jun 25, 2020 – Jun 30, 2020 · Past); Avidity Biosciences, Inc (Director · Jun 11, 2020 – Jun 16, 2020 · Past); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Aug 12, 2019 · Past); Axonics Modulation Technologies Inc (Director · Oct 30, 2018 – Oct 31, 2018 · Past); Constellation Pharmaceuticals Inc (Director · Jul 18, 2018 – Jul 18, 2018 · Past); Kezar Life Sciences, Inc. (Director · Jun 20, 2018 – Jun 25, 2018 · Past); Kiniksa Pharmaceuticals International, plc (Director · May 23, 2018 – May 29, 2018 · Past); Apellis Pharmaceuticals, Inc. (Director · Nov 8, 2017 – Nov 13, 2017 · Past); Kineta Inc. (Director · Nov 3, 2016 – Dec 14, 2017 · Past); Clearside Biomedical Inc (Director · Jun 1, 2016 – Jun 1, 2016 · Past); Cellectar Biosciences, Inc. (Director · Aug 15, 2014 – Aug 15, 2014 · Past)
Board Member · Since at least Aug 6, 2026
John Schmid
Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); Helix Acquisition Corp. III (Director · Since at least Jan 22, 2026); Design Therapeutics, Inc. (Director · Since at least Mar 25, 2021); AnaptysBio, Inc. (Director · Since at least Feb 2, 2018); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Xeris Biopharma Holdings, Inc. (Director · Oct 5, 2021 – Aug 12, 2024 · Past); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); Poseida Therapeutics Inc (Director · Jul 9, 2020 – Jan 8, 2025 · Past); Neos Therapeutics Inc (Director · Jul 2, 2018 – Mar 19, 2021 · Past)
Director · Since at least Aug 6, 2026
Sheila Gujrathi
Other companies: Bolt Biotherapeutics, Inc. (Chief Strategy Officer · Since at least Oct 23, 2026); Processa Pharmaceuticals, Inc. (Director · Since at least Jul 28, 2026); Ventyx Biosciences Inc (Director · Since at least Oct 20, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Jun 15, 2020 · Past); Gossamer Bio, Inc. (President & CEO, Director · Feb 7, 2019 – Feb 14, 2020 · Past); Five Prime Therapeutics Inc (Director · Dec 2, 2015 – May 10, 2018 · Past); Receptos Inc (Chief Medical Officer · May 8, 2013 – Aug 25, 2015 · Past)
Director · Since at least Aug 6, 2026
Jason Keyes
Other companies: Actuate Therapeutics, Inc. (Director · Since at least Aug 12, 2024); Sesen Bio Inc (Director · Feb 24, 2020 – Jun 22, 2022 · Past); Equillium, Inc. (Chief Financial Officer · Oct 11, 2018 – Feb 14, 2025 · Past); Orexigen Therapeutics Inc (EVP, Chief Financial Officer · Jun 8, 2016 – Oct 13, 2017 · Past)
Executive Vice President and Chief Financial Officer · Since at least Aug 6, 2026
Sundeep Agrawal
Other companies: PAVmed Inc. (Director · Since at least Sep 10, 2024); FoxWayne Enterprises Acquisition Corp (Director · Jan 19, 2021 – Jan 19, 2021 · Past)
Board Member · Since at least Aug 6, 2026
Jingrong Jean Cui
Other companies: Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Jun 9, 2020 · Past)
President and CEO, Director · Since at least Aug 6, 2026
Yishan Li
Other companies: Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Apr 16, 2019 · Past)
Executive Chairman, Director · Since at least Aug 6, 2026
Antonio Garrido-MontalbanSenior Vice President, Drug Substance · Since at least Nov 4, 2026
Ashley PrestonSenior Vice President, Head of Regulatory Affairs and Quality Assurance · Since at least Nov 4, 2026
Diane WangSenior Vice President, Clinical Pharmacology and Preclinical Development · Since at least Nov 4, 2026
Eugene Y. RuiSenior Vice President, Chemistry · Since at least Nov 4, 2026
Geoff OxnardExecutive Vice President and Chief Medical Officer · Since at least Oct 22, 2026
Geoffrey Raymond OxnardChief Medical Officer · Since at least Aug 6, 2026
Jihao ZhouSenior Vice President, Biometrics · Since at least Nov 4, 2026
Jill Stuart SmithSenior Vice President, Clinical Operations and Project Management · Since at least Nov 4, 2026
J. Jean CuiScientific Founder, President and CEO · Since at least Nov 4, 2026
Vincent LiptakExecutive Vice President and General Counsel · Since at least Aug 6, 2026
Y. Peter LiCofounder and Executive Chairman · Since at least Nov 5, 2026
Zachary F. ZimmermanSenior Vice President, Clinical Development · Since at least Nov 4, 2026
Z. Jesse ShaoSenior Vice President, CMC · Since at least Nov 4, 2026